✦ LIBER ✦

Does repeated daily testing improve measurement sensitivity to the cognitive effects of donepezil in mild to moderate Alzheimer's disease?

✍ Scribed by Jaeger, Judith; Hardemark, Hans-Goran; Zettergren, Annika; Sjögren, Niclas; Hannesdottir, Kristin

Book ID: 123075659
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 53 KB
Volume: 7
Category: Article
ISSN: 1552-5260
DOI: 10.1016/j.jalz.2011.09.117

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.4.005 Donepezil lengthens time to loss

P.4.005 Donepezil lengthens time to loss of activities of daily living and cognition in patients with mild to moderate alzheimer's disease

✍ L.T. Friedhoff; S.L. Rogers 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Sensitivity of cognition measures in a l

Sensitivity of cognition measures in a longitudinal study of healthy elderly, amnestic MCI and mild-to-moderate Alzheimer's disease

✍ Julie Chandler; Mark Marsico; Xing Shu Zhu; Arwen Markwick; Celeste de Jager 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Updated cost-effectiveness projections f

Updated cost-effectiveness projections for donepezil in the treatment of patients with mild-to-moderately severe Alzheimer's disease in the UK

✍ Maclaine, Grant; Getsios, Denis; Blume, Steve; Ishak, Jack 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A multinational, randomised, 12-week stu

A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease

✍ Roy W. Jones; Hilkka Soininen; Klaus Hager; Dag Aarsland; Peter Passmore; Anita 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB 👁 2 views

## Abstract ## Objectives To compare directly, in the same patient cohort, the ease of use and tolerability of donepezil and galantamine in the treatment of Alzheimer's disease (AD), and investigate the effects of both treatments on cognition and activities of daily living (ADL). ## Methods Pati

PND10 COST-EFFECTIVENESS STUDY IN PATIEN

PND10 COST-EFFECTIVENESS STUDY IN PATIENTS WITH MILD TO MODERATELY SEVERE ALZHEIMER'S DISEASE: PROJECTED BENEFITS OF DONEPEZIL IN THE UNITED KINGDOM

✍ D Getsios; S Blume; KJ Ishak; G MacLaine 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

Effect of cognitive treatment for the el

Effect of cognitive treatment for the elderly with mild-to-moderate Alzheimer's disease in the cognitive function and the psychological well being

✍ Wu, Wei-Ren 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 46 KB